Butterfly Medical

About Butterfly Medical

Butterfly Medical develops an innovative implantable device for the treatment of benign prostatic hyperplasia (BPH). The device offers a minimally invasive, non-surgical procedure that can be performed in clinic, ambulatory surgical centers, or hospital settings and is designed to be long-term yet reversible if needed. The company has CE marking in Europe and is investigational in the United States. Headquartered in Israel, Butterfly Medical has assembled a leadership team with extensive experience in medtech and urology.